|
시장보고서
상품코드
2016044
호흡기 진단 시장 보고서 : 제품 및 서비스 유형별, 검사 유형별, 질환별, 최종사용자별, 지역별(2026-2034년)Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2026-2034 |
||||||
세계의 호흡기 진단 시장 규모는 2025년에 91억 달러에 이르렀습니다. 향후, IMARC Group은 2034년까지 시장 규모가 159억 달러에 이르고, 2026-2034년 CAGR 6.17%를 나타낼 것으로 예측했습니다. 호흡기 질환의 유병률 증가, 의료비 증가, 고령화, 환자의 예후를 개선하고 만성 질환을 효과적으로 관리하기 위한 조기 및 정확한 진단에 대한 수요 증가 등이 시장 성장을 가속하는 요인으로 작용하고 있습니다.
호흡기 진단은 폐 기능 및 관련 과정의 임상적 평가를 말합니다. 여기에는 천식, 만성폐쇄성폐질환(COPD), 폐암, 기관지염, 폐섬유증을 검출하기 위한 여러 가지 기계적, 영상진단 및 분자진단 검사가 포함됩니다. 여기에는 척추측정기, 산소포화도 측정, 경피적 이산화탄소 모니터링, 후비강 흡기압(SNIP), 흉부 엑스레이, 컴퓨터 단층촬영(CT) 스캔 등의 절차가 사용됩니다. 경우에 따라서는 수면무호흡증이나 야간 저호흡증 여부를 진단하고 평가하기 위해 수면검사를 시행하기도 합니다.
호흡기 질환의 유병률 증가는 시장 성장을 이끄는 주요 요인 중 하나입니다. 흡연자 수 증가와 알코올 섭취량 증가에 더해 좌식 생활습관과 스트레스가 많은 일상이 겹치면서 COPD, 폐암 등 심각한 호흡기 질환의 발병률이 높아지고 있습니다. 또한, COPD 진단 및 외래 환자 관리에 사물인터넷(IoT)과 인공지능(AI)의 활용을 포함한 호흡기 진단 검사의 다양한 기술 혁신이 시장 성장에 긍정적인 영향을 미치고 있습니다. 또한, 다양한 민간 병원 및 의료 센터의 호흡기 진단 장비에 대한 수요 증가와 정부 및 비정부기구(NGO)의 모든 사람들이 양질의 의료시설을 이용할 수 있도록 하기 위한 노력이 호흡기 진단 시장을 주도하고 있습니다. 시장 성장에 기여하는 다른 요인으로는 연구개발(R&D) 강화, 고령 인구 증가, 급속한 도시화 및 산업 시설 증가, 전 세계 오염 수준 악화 등이 있습니다.
본 보고서에서 답변을 얻을 수 있는 주요 질문:
- 지금까지 세계 시장 동향은 어떠했으며, 향후 몇 년 동안 어떻게 전개될 것인가?
- 세계 시장에서 호흡기 진단 시장 성장 촉진요인, 억제요인 및 최근 기회는?
- 각 촉진요인, 억제요인 및 기회는 세계 시장에 어떤 영향을 미치고 있는가?
- 주요 지역 시장은?
- 가장 매력적인 시장으로 꼽히는 국가는 어디인가?
- 제품 및 서비스 유형별 시장 현황은?
- 시장에서 가장 매력적인 제품 및 서비스 유형은?
- 검사 유형별 시장 현황은?
- 시장에서 가장 매력적인 검사 유형은?
- 질환별 시장 현황은?
- 시장에서 가장 주목받고 있는 질병은 무엇인가?
- 최종 사용자별 시장 현황은?
- 시장에서 가장 매력적인 최종 사용자는?
- 시장 경쟁 구도는 어떻게 되어 있는가?
- 세계 시장의 주요 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 호흡기 진단 시장
제6장 시장 분석 : 제품 및 서비스 유형별
제7장 시장 분석 : 검사 유형별
제8장 시장 분석 : 질환별
제9장 시장 분석 : 최종사용자별
제10장 시장 분석 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter의 Five Forces 분석
제14장 경쟁 구도
LSHThe global respiratory diagnostics market size reached USD 9.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.17% during 2026-2034. The growing prevalence of respiratory diseases, rising healthcare expenditure, increasing aging population, and heightened demand for early and accurate diagnosis to improve patient outcomes and manage chronic conditions effectively are some of the factors impelling the market growth.
Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.
The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.
Key Market Segmentation:
The publisher provides an analysis of the key respiratory diagnostics market trends in each segment, along with forecasts at the global and regional levels for 2026-2034. Our report has categorized the market based on product and service type, test type, disease, and end-user.
Breakup by Product and Service Type:
- Instruments and Services
- Assays and Reagents
- Services and Software
Breakup by Test Type:
- Mechanical Tests
- Obstructive Sleep Apnoea (OSA) Diagnostic Tests
- Imaging Tests
- Traditional Diagnostic Tests
- Molecular Diagnostic Tests
- Others
Breakup by Disease:
- Tuberculosis
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Lung Cancer
- Others
Breakup by End-User:
- Hospitals
- Clinics
- Reference and Clinical Laboratories
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.
Key Questions Answered in This Report:
- How has the global market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and respiratory diagnostics market recent opportunities in the global market?
- What is the impact of each driver, restraint, and opportunity on the global market?
- What are the key regional markets?
- Which countries represent the most attractive market?
- What is the breakup of the market based on the product and service type?
- Which is the most attractive product and service type in the market?
- What is the breakup of the market based on the test type?
- Which is the most attractive test type in the market?
- What is the breakup of the market based on the disease?
- Which is the most attractive disease in the market?
- What is the breakup of the market based on the end-user?
- Which is the most attractive end-user in the market?
- What is the competitive structure of the market?
- Who are the key players/companies in the global market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Respiratory Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Breakup by Product and Service Type
- 5.5 Market Breakup by Test Type
- 5.6 Market Breakup by Disease
- 5.7 Market Breakup by End-User
- 5.8 Market Breakup by Region
- 5.9 Market Forecast
6 Market Breakup by Product and Service Type
- 6.1 Instruments and Services
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Assays and Reagents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Services and Software
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Test Type
- 7.1 Mechanical Tests
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Imaging Tests
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Traditional Diagnostic Tests
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Molecular Diagnostic Tests
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Disease
- 8.1 Tuberculosis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Asthma
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Chronic Obstructive Pulmonary Disease (COPD)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Lung Cancer
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Reference and Clinical Laboratories
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Europe
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Asia Pacific
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Middle East and Africa
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
- 10.5 Latin America
- 10.5.1 Market Trends
- 10.5.2 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Philips Healthcare
- 14.3.2 Abbott Laboratories
- 14.3.3 Biomerieux
- 14.3.4 Becton Dickinson
- 14.3.5 Thermo Fisher Scientific Inc.
- 14.3.6 Alere Inc.
- 14.3.7 Seegene Inc.
- 14.3.8 3M
- 14.3.9 Bio-Rad Laboratories Inc.
- 14.3.10 SDI Diagnostics
- 14.3.11 COSMED
